Court Dismisses RICO Claims Against Insulin Makers

Drug Industry Daily
A A
A federal judge in New Jersey ruled that a class of diabetes patients cannot sue insulin manufacturers under the Racketeer Influenced and Corrupt Organizations (RICO) Act because they did not buy the drugs directly from the manufacturers.

To View This Article:

Login

Subscribe To Drug Industry Daily